These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines. Kitazono-Saitoh M; Takiguchi Y; Kitazono S; Ashinuma H; Kitamura A; Tada Y; Kurosu K; Sakaida E; Sekine I; Tanabe N; Tagawa M; Tatsumi K Oncol Rep; 2012 Jul; 28(1):33-40. PubMed ID: 22562354 [TBL] [Abstract][Full Text] [Related]
23. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells. Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956 [TBL] [Abstract][Full Text] [Related]
24. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772 [TBL] [Abstract][Full Text] [Related]
25. Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction. Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR Int J Oncol; 2014 Oct; 45(4):1769-77. PubMed ID: 25096993 [TBL] [Abstract][Full Text] [Related]
26. Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1. Krause DR; Jonnalagadda JC; Gatei MH; Sillje HH; Zhou BB; Nigg EA; Khanna K Oncogene; 2003 Sep; 22(38):5927-37. PubMed ID: 12955071 [TBL] [Abstract][Full Text] [Related]
27. Aspirin blocks proliferation in colon cells by inducing a G1 arrest and apoptosis through activation of the checkpoint kinase ATM. Luciani MG; Campregher C; Gasche C Carcinogenesis; 2007 Oct; 28(10):2207-17. PubMed ID: 17510082 [TBL] [Abstract][Full Text] [Related]
28. Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program. Jänne PA; Wozniak AJ; Belani CP; Keohan ML; Ross HJ; Polikoff JA; Mintzer DM; Ye Z; Monberg MJ; Obasaju CK; J Thorac Oncol; 2006 Jul; 1(6):506-12. PubMed ID: 17409909 [TBL] [Abstract][Full Text] [Related]
29. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Gordon GJ; Mani M; Maulik G; Mukhopadhyay L; Yeap BY; Kindler HL; Salgia R; Sugarbaker DJ; Bueno R Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864 [TBL] [Abstract][Full Text] [Related]
31. Biochemical characterization of the ataxia-telangiectasia mutated (ATM) protein from human cells. Goodarzi AA; Lees-Miller SP DNA Repair (Amst); 2004 Jul; 3(7):753-67. PubMed ID: 15177184 [TBL] [Abstract][Full Text] [Related]
32. Loss of RPA1 induces Chk2 phosphorylation through a caffeine-sensitive pathway. Araya R; Hirai I; Meyerkord CL; Wang HG FEBS Lett; 2005 Jan; 579(1):157-61. PubMed ID: 15620706 [TBL] [Abstract][Full Text] [Related]
33. Role of Chk1 and Chk2 in Ara-C-induced differentiation of human leukemia K562 cells. Takagaki K; Katsuma S; Kaminishi Y; Horio T; Tanaka T; Ohgi T; Yano J Genes Cells; 2005 Feb; 10(2):97-106. PubMed ID: 15676021 [TBL] [Abstract][Full Text] [Related]
34. Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition. Racanelli AC; Rothbart SB; Heyer CL; Moran RG Cancer Res; 2009 Jul; 69(13):5467-74. PubMed ID: 19549896 [TBL] [Abstract][Full Text] [Related]
35. Molecular pathways involved in the synergistic interaction of the PKC beta inhibitor enzastaurin with the antifolate pemetrexed in non-small cell lung cancer cells. Tekle C; Giovannetti E; Sigmond J; Graff JR; Smid K; Peters GJ Br J Cancer; 2008 Sep; 99(5):750-9. PubMed ID: 18728666 [TBL] [Abstract][Full Text] [Related]
37. Interaction of pemetrexed disodium (ALIMTA, multitargeted antifolate) and irradiation in vitro. Bischof M; Weber KJ; Blatter J; Wannenmacher M; Latz D Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1381-8. PubMed ID: 11955753 [TBL] [Abstract][Full Text] [Related]
38. A novel folate transport activity in human mesothelioma cell lines with high affinity and specificity for the new-generation antifolate, pemetrexed. Wang Y; Zhao R; Chattopadhyay S; Goldman ID Cancer Res; 2002 Nov; 62(22):6434-7. PubMed ID: 12438230 [TBL] [Abstract][Full Text] [Related]
40. Assessment of ATM phosphorylation on Ser-1981 induced by DNA topoisomerase I and II inhibitors in relation to Ser-139-histone H2AX phosphorylation, cell cycle phase, and apoptosis. Kurose A; Tanaka T; Huang X; Halicka HD; Traganos F; Dai W; Darzynkiewicz Z Cytometry A; 2005 Nov; 68(1):1-9. PubMed ID: 16184611 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]